Literature DB >> 6190849

Presence of fibroblast-type intermediate filaments (vimentin) and absence of neurofilaments in pigmented nevi and malignant melanomas.

M Miettinen, V P Lehto, I Virtanen.   

Abstract

The cytoskeletal intermediate filaments of pigmented nevi and malignant melanomas (nine cases of each) were evaluated using monospecific antibodies against intermediate filament proteins and immunofluorescence microscopy. Both pigmented nevi and cutaneous malignant melanomas showed only vimentin-type intermediate filaments, but not keratin, neurofilaments, desmin or glial fibrillary acidic protein. Thus, nevi and melanomas do not show neural characteristics in the cytoskeletal intermediate filament pattern although they appear to show other neural markers. Vimentin - content in melanomas versus keratin - content in carcinomas may be used as a differential diagnostic feature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190849     DOI: 10.1111/j.1600-0560.1983.tb00325.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.

Authors:  Ryan C Romano; Jodi M Carter; Andrew L Folpe
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

2.  Evaluation of molecular markers of mesenchymal phenotype in melanoma.

Authors:  Leann M Mikesh; Manish Kumar; Gulsun Erdag; Kevin T Hogan; Kerrington R Molhoek; Marty W Mayo; Craig L Slingluff
Journal:  Melanoma Res       Date:  2010-12       Impact factor: 3.599

3.  Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.

Authors:  M R Wick; D L Cherwitz; R C McGlennen; L P Dehner
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

4.  Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma.

Authors:  Elizabeth S Borden; Anngela C Adams; Kenneth H Buetow; Melissa A Wilson; Julie E Bauman; Clara Curiel-Lewandrowski; H-H Sherry Chow; Bonnie J LaFleur; Karen Taraszka Hastings
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.